Trial intelligence / Profile preview

Weekly Prednisone in BMD and LGMD

NCT04054375Phase 2Completed

Sponsor
Northwestern University
Start
Jul 2019
Primary completion
Jun 2020
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of prednisone in Becker muscular dystrophy (BMD), limb-girdle muscular dystrophy (LGMD), sponsored by Northwestern University. Started Jul 2019; status: completed.

02

Drugs

prednisone
03

Conditions

Becker muscular dystrophy (BMD)limb-girdle muscular dystrophy (LGMD)

Beyond the preview

Go deeper on NCT04054375.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04054375.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call